Ocular Therapeutix (OCUL) EBITDA Margin Growth (3y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -40,178.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 530.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -932.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 7,003.00 |
| 10 | Ocular Therapeutix | 1.99 Bn | 1.99 Bn | 9.46 Mn | -69,686.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -69,686.00 |
| Dec 31, 2025 | -38,893.00 |
| Sep 30, 2025 | -29,229.00 |
| Jun 30, 2025 | -34,020.00 |
| Mar 31, 2025 | -46,224.00 |
| Dec 31, 2024 | -14,943.00 |
| Sep 30, 2024 | -13,751.00 |
| Jun 30, 2024 | -9,248.00 |
| Mar 31, 2024 | 6,151.00 |
| Dec 31, 2023 | 5,971.00 |
| Sep 30, 2023 | 11,095.00 |
| Jun 30, 2023 | 100,438.00 |
| Mar 31, 2023 | 46,819.00 |
| Dec 31, 2022 | 81,107.00 |
| Sep 30, 2022 | 261,174.00 |
| Jun 30, 2022 | 316,056.00 |
| Mar 31, 2022 | 386,030.00 |
| Dec 31, 2021 | 330,554.00 |
| Sep 30, 2021 | 285,336.00 |
| Jun 30, 2021 | 195,760.00 |
| Mar 31, 2021 | 377,302.00 |
| Dec 31, 2020 | 249,518.00 |
| Sep 30, 2020 | 273,812.00 |
| Jun 30, 2020 | 312,615.00 |
| Mar 31, 2020 | 273,731.00 |
| Dec 31, 2019 | 156,253.00 |
| Sep 30, 2019 | -77,901.00 |
| Jun 30, 2019 | -72,995.00 |
| Mar 31, 2019 | -140,611.00 |
| Dec 31, 2018 | -73,924.00 |
| Sep 30, 2018 | 2.51 Mn |
| Jun 30, 2018 | 5,211.00 |
| Mar 31, 2018 | -86,450.00 |
| Dec 31, 2017 | -111,530.00 |
| Sep 30, 2017 | 212,422.00 |
| Jun 30, 2017 | 232,371.00 |
| Mar 31, 2017 | 2.19 Mn |